An array of advanced technologies at your disposal to address your molecule’s challenges and processing hurdles effectively, achieving the optimal dosage form.
This document provides both a high-level overview of Hycon’s stand-alone small molecule analytical services, and a detailed list of services organized by…
A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in…
Quality by Design (QbD) is a well-known pharmaceutical industry strategy for enhancing production processes, including active pharmaceutical ingredients and medicinal products. Companies…
It is typical to encounter a restricted number of APIs during the initial stages of drug development. This limitation hinders the swift…
If scientific literature indicates that elements are not likely to be present in drug product components, and no additional elements are added…
Comparing the dissolution rates and pellet fine structure of branded Zovirax® with three similar acyclovir generic products marketed across the world, all…